TipRanks
Clinuvel Pharmaceuticals Limited (DE:UR9)
FRANKFURT:UR9
Germany Market
UR9
Clinuvel Pharmaceuticals
RESEARCH TOOLSreports

Clinuvel Pharmaceuticals (UR9) Cash flow

2 Followers

Clinuvel Pharmaceuticals Cash Flow

DE:UR9's free cash flow for Q4 2026 was AU$22.93M. For the 2026 fiscal year, DE:UR9's free cash flow was decreased by AU$-5.49M and operating cash flow was AU$24.38M. See a summary of the company’s cash flow.
Cash Flow
Jun 26Jun 25Jun 24Jun 23Jun 22
Operating Cash Flow
AU$ 36.91MAU$ 41.10MAU$ 37.05MAU$ 36.91MAU$ 39.87M
Investing Cash Flow
AU$ -39.12MAU$ -47.72MAU$ -29.03MAU$ -1.03MAU$ -434.44K
Financing Cash Flow
AU$ -2.75MAU$ -2.94MAU$ -3.57MAU$ -2.24MAU$ -1.50M
End Cash Position
AU$ 20.43MAU$ 28.02MAU$ 35.20MAU$ 23.87MAU$ 27.41M
Free Cash Flow
AU$ 35.31MAU$ 40.80MAU$ 31.48MAU$ 35.88MAU$ 39.44M
Currency in AUD

Clinuvel Pharmaceuticals Cash Flow